Zheng, Y <br/><br/>
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.  [electronic resource] 

 -  Leukemia  Mar 2013 
 - 702-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2012.272  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Bone Marrow--drug effects<br/>CD18 Antigens--genetics<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Immunoenzyme Techniques<br/>Immunoprecipitation<br/>Intercellular Adhesion Molecule-1--genetics<br/>Macrophages--drug effects<br/>Melphalan--pharmacology<br/>Membrane Glycoproteins--genetics<br/>Mice<br/>Mice, SCID<br/>Multiple Myeloma--drug therapy<br/>P-Selectin--genetics<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Cells, Cultured<br/>Tumor Microenvironment